Skip to content
naulon

Not checkedNot checked for notices yet.

Pregnancy and SARS-CoV-2: an opportunity to systematically study the complexity of maternal health

Elizabeth Barr, Damiya Whitaker, Pamela Stratton

The Lancet: Digital Health · 2022

doi:10.1016/s2589-7500(21)00277-6 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Despite a worldwide, strategic, rapid, multi-pronged approach to developing viral-specific testing, therapeutics, and vaccines as the SARS-CoV-2 pandemic unfolded and its pathobiology became understood, the scientifically complex population of pregnant people were routinely excluded from these clinical trials.1 Nearly 2 years later, an information gap on pregnancy-specific therapeutics or vaccines for SARS-CoV-2 persists. Using electronic health records, Samantha Piekos and colleagues2 contribute to the evolving knowledge on birth outcomes modified by the pregnancy trimester in which the infection occurred.

Abstract licence: CC BY-NC

References5

    5 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.